Sarepta's muscular dystrophy therapy fails to meet main goal in late-stage trial – CNBC

Sarepta's gene therapy to treat Duchenne muscular dystrophy (DMD), a progressive muscle-wasting disorder, failed to meet the main goal of a …

scroll to top